Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy

por De Rycke, L, Baeten, D, Foell, D, Veys, EM, De Keyser, F, Roth, J
Publicado 2003

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies

por van Damme, N, de Rycke, L, Kruithof, E, Hoffman, IEA, Veys, EM, de Keyser, F
Publicado 2002

The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients

por Baeten, D, Kruithof, E, Hoffman, IEA, De Rycke, L, Vandooren, B, Veys, EM, De Keyser, F
Publicado 2003

Differential expression and response to infliximab treatment of specific macrophage subsets in inflammatory synovitis

por De Rycke, L, Baeten, D, Foell, D, Kruithof, E, Veys, EM, Roth, J, De Keyser, F
Publicado 2004

The effect of infliximab on skin lesions in a patient with scleroderma (CREST)

por De Rycke, L, Baeten, D, Van den Bosch, F, Mielants, H, De Keyser, F, Veys, EM
Publicado 2004

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis

por De Rycke, L, Baeten, D, Foell, D, Kruithof, E, Veys, EM, Roth, J, De Keyser, F
Publicado 2004

Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment

por De Rycke, L, Kruithof, E, Van Damme, N, Hoffman, IEA, Van den Bosch, F, Veys, EM, De Keyser, F
Publicado 2003